Abstract
The research article responds to the need for assessing a steadily increasing number of publication material devoted to contraceptive products. By way of a critical analysis it is found that an unexpected high number of health agencies and publishers disseminate heterodoxies and flawed science on contraception. To avert continuation of flawed science and perpetuation of error, it is suggested that health agencies involve only competent researchers in the production of their information material, that editors refrain from publishing adulterated research conducted by authors with conflicting interests, and that pharmacovigilance expands its activities and assesses -- under the nomenclature “pharmaceuticovigilance” -- the documents generated by manufacturers for approval as well as for effective marketing of their products.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
